Literature DB >> 26857217

High prevalence of hypogonadism and associated impaired metabolic and bone mineral status in subfertile men.

Johannes Bobjer1,2,3, Karolina Bogefors1,3,4, Sigrid Isaksson1,3,4, Irene Leijonhufvud1,3, Kristina Åkesson5,6, Yvonne Lundberg Giwercman7, Aleksander Giwercman1,3.   

Abstract

OBJECTIVE: It is yet unknown to which degree young subfertile men present with signs of hypogonadism and whether low testosterone concentration, like in older men, is associated with risk of osteoporosis and metabolic derangements in those subjects. The objective was therefore to investigate the prevalence of hypogonadism and its association with metabolic and bone parameters in young subfertile men.
DESIGN: Cross-sectional case-control study. PATIENTS: Men from infertile couples (n = 192); 18-50 years; sperm concentration <20 × 10(6) /ml and population-based age-matched controls (n = 199). MEASUREMENTS: Blood sampling, anthropometrics, blood pressure, ankle-brachial index and assessment by dual-energy X-ray absorptiometry were undertaken. Odds ratios of biochemical hypogonadism (total testosterone <8·0 nmol/l and/or luteinizing hormone ≥8·6 IU/l and/or ongoing androgen replacement therapy) were calculated. Serum concentrations of sex hormones, lipids, glucose, insulin and HbA1c were assessed and bone mineral density (BMD) evaluated.
RESULTS: Compared to controls, the risk of hypogonadism was increased among subfertile men (OR 10; 95% CI, 5·1, 22), being highest in those with nonobstructive azoospermia. Hypogonadal men had higher HbA1c concentration (mean diff. 2·8 mmol/mol; 95% CI, 0·64, 4·9; P = 0·011) and lower lumbar spine BMD (mean diff. 0·05 g/cm(2) ; 95% CI, 0·01, 0·10; P = 0·032) compared to eugonadal subfertile men, even more pronounced in subfertile men with subnormal testosterone levels.
CONCLUSION: Young subfertile men have 10 times increased OR of hypogonadism, which is linked to increased HbA1c and decreased bone mineralization. Endocrine assessment and, if needed, measures to prevent metabolic sequelae and osteoporosis should be included in the routine management of men from infertile couples.
© 2016 John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26857217     DOI: 10.1111/cen.13038

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  12 in total

1.  Quality of life among female childhood cancer survivors with and without premature ovarian insufficiency.

Authors:  Hjelmér Ida; Gustafsson Kylberg Alicia; Fridenborg Anna; Leijonhufvud Irene; Nyström Anna; Mörse Helena; Elfving Maria; Henic Emir; Nenonen Hannah
Journal:  J Cancer Surviv       Date:  2021-01-19       Impact factor: 4.442

Review 2.  BMI and BMD: The Potential Interplay between Obesity and Bone Fragility.

Authors:  Andrea Palermo; Dario Tuccinardi; Giuseppe Defeudis; Mikiko Watanabe; Luca D'Onofrio; Angelo Lauria Pantano; Nicola Napoli; Paolo Pozzilli; Silvia Manfrini
Journal:  Int J Environ Res Public Health       Date:  2016-05-28       Impact factor: 3.390

3.  Serum microRNAs in male subfertility-biomarkers and a potential pathogenetic link to metabolic syndrome.

Authors:  Dorota Trzybulska; Johannes Bobjer; Aleksander Giwercman; Christos Tsatsanis
Journal:  J Assist Reprod Genet       Date:  2017-06-29       Impact factor: 3.412

Review 4.  Male Hypogonadism and Osteoporosis: The Effects, Clinical Consequences, and Treatment of Testosterone Deficiency in Bone Health.

Authors:  Gary Golds; Devon Houdek; Terra Arnason
Journal:  Int J Endocrinol       Date:  2017-03-16       Impact factor: 3.257

5.  Risk of metabolic disorders in childless men: a population-based cohort study.

Authors:  Ane Berger Bungum; Clara Helene Glazer; Jens Peter Bonde; Peter M Nilsson; Aleksander Giwercman; Sandra Søgaard Tøttenborg
Journal:  BMJ Open       Date:  2018-08-17       Impact factor: 2.692

6.  More Prevalent Prescription of Medicine for Hypertension and Metabolic Syndrome in Males from Couples Undergoing Intracytoplasmic Sperm Injection.

Authors:  A Elenkov; Y Al-Jebari; A Giwercman
Journal:  Sci Rep       Date:  2018-09-28       Impact factor: 4.379

7.  Risk of prostate cancer for men fathering through assisted reproduction: nationwide population based register study.

Authors:  Yahia Al-Jebari; Angel Elenkov; Elin Wirestrand; Indra Schütz; Aleksander Giwercman; Yvonne Lundberg Giwercman
Journal:  BMJ       Date:  2019-09-25

8.  Impact of genetic risk score on the association between male childlessness and cardiovascular disease and mortality.

Authors:  Angel Elenkov; Olle Melander; Peter M Nilsson; He Zhang; Aleksander Giwercman
Journal:  Sci Rep       Date:  2021-09-17       Impact factor: 4.379

9.  Novel protein markers of androgen activity in humans: proteomic study of plasma from young chemically castrated men.

Authors:  Aniel Sanchez; Johan Malm; Aleksander Giwercman; K Barbara Sahlin; Indira Pla Parada; Krzysztof Pawlowski; Carl Fehninger; Yvonne Lundberg Giwercman; Irene Leijonhufvud; Roger Appelqvist; György Marko-Varga
Journal:  Elife       Date:  2022-03-01       Impact factor: 8.713

10.  Testosterone replacement therapy in men who conceived with intracytoplasmic sperm injection: nationwide register study.

Authors:  Angel Elenkov; Yahia Al-Jebari; Yvonne Lundberg Giwercman; Aleksander Giwercman
Journal:  Eur J Endocrinol       Date:  2020-04       Impact factor: 6.664

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.